H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA), with a price target of $18.00. This aligns with the strong overall analyst consensus, as ...
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for ...
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...
cirm.ca.gov5 天
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease ...
South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
My daughter was healthy, fit and an athlete – then she died at 20
My daughter Clarissa was full of energy and kindness, she had a magnetic presence that made everyone feel special. At 20, she ...